Literature DB >> 26252773

The Overexpression of IQGAP1 and β-Catenin Is Associated with Tumor Progression in Hepatocellular Carcinoma In Vitro and In Vivo.

Xuewen Jin1, Yuling Liu1, Jingjing Liu1, Weiliang Lu1, Ziwei Liang1, Dan Zhang1, Gang Liu2, Hongxia Zhu3, Ningzhi Xu3, Shufang Liang1.   

Abstract

The IQ-domain GTPase-activating protein 1 (IQGAP1) is a multifunctional scaffold protein, which interacts with diverse proteins to regulate cell adhesion and cell migration. The abnormal expression of IQGAP1 widely exists in many cancers, but biological roles of IQGAP1 cooperation with its interacting proteins to involve in tumorigenesis remain to clarify. In this study, we have found that IQGAP1 interacts with β-catenin and regulates β-catenin expression in hepatocellular carcinoma (HCC) cells. The expression levels of IQGAP1 and β-catenin and their associations have a positive correlation with cell metastasis ability in several HCC cell lines. The up-regulation of IQGAP1 and β-catenin improves cell proliferation and migration ability of HCC cells, whereas the knockdown of IQGAP1 by small interfering RNA can decrease β-catenin expression, which results in the reduction of cell proliferation and migration ability in vitro. In addition, a significantly higher expression of IQGAP1 and β-catenin also usually exists in human HCC tissues, especially their overexpression is clinicopathologically associated with tumor malignancy. Generally the overexpression and interactions of IQGAP1 and β-catenin contribute to HCC progression by promoting cell proliferation and migration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26252773      PMCID: PMC4529304          DOI: 10.1371/journal.pone.0133770

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  36 in total

1.  Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex.

Authors:  Vivian S W Li; Ser Sue Ng; Paul J Boersema; Teck Y Low; Wouter R Karthaus; Jan P Gerlach; Shabaz Mohammed; Albert J R Heck; Madelon M Maurice; Tokameh Mahmoudi; Hans Clevers
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

2.  Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells.

Authors:  Soichi Iwai; Atsuko Yonekawa; Chie Harada; Masakazu Hamada; Wataru Katagiri; Mituhiro Nakazawa; Yoshiaki Yura
Journal:  Int J Oncol       Date:  2010-11       Impact factor: 5.650

3.  IQGAP1 protein regulates nuclear localization of β-catenin via importin-β5 protein in Wnt signaling.

Authors:  Toshiyasu Goto; Atsushi Sato; Shungo Adachi; Shun-ichiro Iemura; Tohru Natsume; Hiroshi Shibuya
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

4.  RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

Authors:  Kendra S Carmon; Xing Gong; Jing Yi; Anthony Thomas; Qingyun Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

5.  Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.

Authors:  Darren E Casteel; Stephanie Turner; Raphaela Schwappacher; Hema Rangaswami; Jacqueline Su-Yuo; Shunhui Zhuang; Gerry R Boss; Renate B Pilz
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

6.  Enrichment of the β-catenin-TCF complex at the S and G2 phases ensures cell survival and cell cycle progression.

Authors:  Yajie Ding; Shang Su; Weixin Tang; Xiaolei Zhang; Shengyao Chen; Guixin Zhu; Juan Liang; Wensheng Wei; Ye Guo; Lei Liu; Ye-Guang Chen; Wei Wu
Journal:  J Cell Sci       Date:  2014-09-18       Impact factor: 5.285

7.  Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation.

Authors:  Anna P Lam; Annette S Flozak; Susan Russell; Jun Wei; Manu Jain; Gökhan M Mutlu; G R Scott Budinger; Carol A Feghali-Bostwick; John Varga; Cara J Gottardi
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-31       Impact factor: 6.914

8.  Critical roles of p53 in epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma cells.

Authors:  Zheng Wang; Yuhui Jiang; Dongxian Guan; Jingjing Li; Hongkun Yin; Yi Pan; Dong Xie; Yan Chen
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

Review 9.  Scaffold proteins: hubs for controlling the flow of cellular information.

Authors:  Matthew C Good; Jesse G Zalatan; Wendell A Lim
Journal:  Science       Date:  2011-05-06       Impact factor: 47.728

10.  Targeted knockdown of IQGAP1 inhibits the progression of esophageal squamous cell carcinoma in vitro and in vivo.

Authors:  Xiao-Xia Wang; Kang Wang; Xiao-Zhong Li; Li-Qin Zhai; Chong-Xiao Qu; Yan Zhao; Zhi-Rong Liu; Hui-Zhen Wang; Qi-Jun An; Li-Wei Jing; Xu-Hong Wang
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more
  20 in total

1.  Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma.

Authors:  Mauro Montalbano; Cristiana Rastellini; Joshua T McGuire; Janika Prajapati; Ali Shirafkan; Renza Vento; Luca Cicalese
Journal:  Cell Oncol (Dordr)       Date:  2017-12-04       Impact factor: 6.730

2.  A PI3K/AKT Scaffolding Protein, IQ Motif-Containing GTPase Associating Protein 1 (IQGAP1), Promotes Head and Neck Carcinogenesis.

Authors:  Tao Wei; Suyong Choi; Darya Buehler; Richard A Anderson; Paul F Lambert
Journal:  Clin Cancer Res       Date:  2019-10-09       Impact factor: 12.531

Review 3.  Role of IQ Motif-Containing GTPase-Activating Proteins in Hepatocellular Carcinoma.

Authors:  Qingqing Dai; Quratul Ain; Michael Rooney; Fei Song; Alexander Zipprich
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

4.  Downregulation of ARHGDIA contributes to human glioma progression through activation of Rho GTPase signaling pathway.

Authors:  Weiliang Lu; Xixi Wang; Jingjing Liu; Yu He; Ziwei Liang; Zijing Xia; Ying Cai; Liangxue Zhou; Hongxia Zhu; Shufang Liang
Journal:  Tumour Biol       Date:  2016-10-10

5.  PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments.

Authors:  Dan Zhang; Xiangying Xia; Xixi Wang; Peng Zhang; Weiliang Lu; Yamei Yu; Shi Deng; Hanshuo Yang; Hongxia Zhu; Ningzhi Xu; Shufang Liang
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

6.  Inhibition of HSP90 sensitizes a novel Raf/ERK dual inhibitor CY-9d in triple-negative breast cancer cells.

Authors:  Yujuan Chen; Xiaoyun Wang; Chuan Cao; Xiaodong Wang; Shufang Liang; Cheng Peng; Leilei Fu; Gu He
Journal:  Oncotarget       Date:  2017-10-26

7.  Downregulation of ATP1A1 promotes cancer development in renal cell carcinoma.

Authors:  Dan Zhang; Peng Zhang; Pengbo Yang; Yu He; Xixi Wang; Yanfang Yang; Hongxia Zhu; Ningzhi Xu; Shufang Liang
Journal:  Clin Proteomics       Date:  2017-05-04       Impact factor: 3.988

8.  Elevated IQGAP1 and CDC42 levels correlate with tumor malignancy of human glioma.

Authors:  Xiaobo Cui; Laixiao Song; Yunfei Bai; Yaping Wang; Boqian Wang; Wei Wang
Journal:  Oncol Rep       Date:  2016-12-29       Impact factor: 3.906

9.  High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation.

Authors:  Jia-Jia He; Lei Shang; Qun-Wei Yu; Ning Jiao; Shuang Qiu; Wei-Xiong Zhu; Dong-Feng Wu; Yun-Er Tian; Qing Zhang
Journal:  World J Gastrointest Oncol       Date:  2021-07-15

10.  In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cells.

Authors:  Jingjing Liu; Yu He; Dan Zhang; Ying Cai; Chenggang Zhang; Peng Zhang; Hongxia Zhu; Ningzhi Xu; Shufang Liang
Journal:  Mol Med Rep       Date:  2017-06-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.